Difficulty: Medium
Average Score: 95%
Practice
Which patient should be most carefully assessed for fluid and electrolyte imbalance among those receiving the following drugs?
Correct answer
A
Rationale
Lithium (Eskalith) is the correct choice because it has a narrow therapeutic index and is excreted almost entirely by the kidneys, making patients highly susceptible to fluid and electrolyte imbalances. Lithium levels are directly influenced by sodium and water balanceÔÇödehydration or sodium loss can lead to lithium retention and toxicity, manifesting as confusion, tremors, seizures, or even coma. Patients on lithium require strict monitoring of serum levels (typically 0.6ÔÇô1.2 mEq/L), renal function, and hydration status. Diuretics, excessive sweating, or gastrointestinal losses (e.g., vomiting/diarrhea) further increase the risk, necessitating vigilant assessment.
Clozapine (Clozaril) primarily requires monitoring for agranulocytosis, metabolic disturbances (e.g., weight gain, dyslipidemia), and myocarditis, but it does not directly cause electrolyte imbalances. While it may induce hypersalivation or constipation, these side effects are less likely to disrupt fluid or electrolyte homeostasis compared to lithium.
Diazepam (Valium), a benzodiazepine, has minimal impact on fluid or electrolyte balance. Its primary risks include sedation, respiratory depression, and dependence. Any fluid-related issues (e.g., dehydration) would be secondary to reduced oral intake due to excessive drowsiness, not a direct pharmacological effect.
Amitriptyline, a tricyclic antidepressant, can cause anticholinergic effects (e.g., dry mouth, urinary retention) and orthostatic hypotension, but these do not typically lead to significant electrolyte disturbances. While overdose can cause cardiac arrhythmias due to sodium channel blockade, routine therapeutic use does not necessitate the same level of fluid/electrolyte monitoring as lithium.
The critical distinction lies in lithiumÔÇÖs unique pharmacokinetics: its renal excretion and dependence on sodium balance create a direct, dose-dependent risk for life-threatening toxicity if hydration or electrolytes are not meticulously managed. No other drug listed poses such an immediate and predictable threat to fluid-electrolyte equilibrium. Monitoring for clozapine, diazepam, or amitriptyline focuses on entirely different adverse effects, none of which are as intrinsically tied to fluid and electrolyte status.
Clozapine (Clozaril) primarily requires monitoring for agranulocytosis, metabolic disturbances (e.g., weight gain, dyslipidemia), and myocarditis, but it does not directly cause electrolyte imbalances. While it may induce hypersalivation or constipation, these side effects are less likely to disrupt fluid or electrolyte homeostasis compared to lithium.
Diazepam (Valium), a benzodiazepine, has minimal impact on fluid or electrolyte balance. Its primary risks include sedation, respiratory depression, and dependence. Any fluid-related issues (e.g., dehydration) would be secondary to reduced oral intake due to excessive drowsiness, not a direct pharmacological effect.
Amitriptyline, a tricyclic antidepressant, can cause anticholinergic effects (e.g., dry mouth, urinary retention) and orthostatic hypotension, but these do not typically lead to significant electrolyte disturbances. While overdose can cause cardiac arrhythmias due to sodium channel blockade, routine therapeutic use does not necessitate the same level of fluid/electrolyte monitoring as lithium.
The critical distinction lies in lithiumÔÇÖs unique pharmacokinetics: its renal excretion and dependence on sodium balance create a direct, dose-dependent risk for life-threatening toxicity if hydration or electrolytes are not meticulously managed. No other drug listed poses such an immediate and predictable threat to fluid-electrolyte equilibrium. Monitoring for clozapine, diazepam, or amitriptyline focuses on entirely different adverse effects, none of which are as intrinsically tied to fluid and electrolyte status.